Brief: Avrobio Completes Sale Of Cystinosis Gene Therapy Program For $87.5 Million
12/06/2023 12:01
June 12 (Reuters) - AVROBIO Inc AVRO.O :
* AVROBIO COMPLETES SALE OF CYSTINOSIS GENE THERAPY PROGRAM
FOR
$87.5 MILLION
Source text for Eikon: ID:nBw7JVyDra
Further company coverage: AVRO.O
Recent news on Tectonic Therapeutic
See all newsTectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary
Tectonic Therapeutic Q2 net loss widens on higher costs
Tectonic Therapeutic Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Tectonic Therapeutic Completes Enrollment In Tx45 Apex Phase 2 Clinical Trial In Ph-Hfpef Patients
Tectonic Therapeutic Q1 net loss widens on higher R&D costs